Quantinno Capital Management LP Acquires 10,887 Shares of Dolby Laboratories $DLB

Quantinno Capital Management LP boosted its holdings in Dolby Laboratories (NYSE:DLBFree Report) by 23.0% in the first quarter, HoldingsChannel reports. The firm owned 58,316 shares of the electronics maker’s stock after purchasing an additional 10,887 shares during the period. Quantinno Capital Management LP’s holdings in Dolby Laboratories were worth $3,503,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp grew its holdings in Dolby Laboratories by 8.7% in the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock worth $167,906,000 after purchasing an additional 180,072 shares during the period. First Trust Advisors LP increased its holdings in Dolby Laboratories by 19.9% during the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after purchasing an additional 374,405 shares in the last quarter. Geode Capital Management LLC grew its holdings in Dolby Laboratories by 15.6% during the fourth quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock worth $122,749,000 after buying an additional 254,250 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of Dolby Laboratories by 51.8% in the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after acquiring an additional 592,282 shares in the last quarter. Finally, Snyder Capital Management L P grew its position in Dolby Laboratories by 24.4% in the 4th quarter. Snyder Capital Management L P now owns 1,427,093 shares of the electronics maker’s stock worth $91,648,000 after purchasing an additional 279,743 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $54.90, for a total transaction of $164,700.00. Following the sale, the senior vice president owned 80,603 shares in the company, valued at $4,425,104.70. This represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $60.00, for a total value of $460,020.00. Following the completion of the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at $7,123,620. The trade was a 6.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 43,128 shares of company stock worth $2,405,917. Insiders own 37.93% of the company’s stock.

Wall Street Analysts Forecast Growth

DLB has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, July 31st. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $90.75.

View Our Latest Stock Report on Dolby Laboratories

Dolby Laboratories Stock Up 1.3%

NYSE DLB opened at $61.70 on Friday. The company has a market cap of $5.78 billion, a PE ratio of 26.26 and a beta of 0.80. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $75.66. The firm’s 50-day simple moving average is $52.82 and its two-hundred day simple moving average is $58.49.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.02. The firm had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company’s revenue was down 3.3% on a year-over-year basis. During the same quarter last year, the company earned $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities research analysts anticipate that Dolby Laboratories will post 3.24 EPS for the current year.

Dolby Laboratories announced that its Board of Directors has authorized a stock buyback plan on Thursday, July 30th that authorizes the company to buyback $350.00 million in outstanding shares. This buyback authorization authorizes the electronics maker to purchase up to 7% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be issued a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.3%. Dolby Laboratories’s payout ratio is presently 61.28%.

About Dolby Laboratories

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Recommended Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.